CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-08 | Blake John T Senior Vice President, Finance | Sale | −1,402 | $3.40 | $5K | 1,932 |
| 2018-02-07 | Blake John T Senior Vice President, Finance | Exercise or conversion | +3,334 | 3,334 | ||
| 2018-02-07 | Blake John T Senior Vice President, Finance | Exercise or conversion · Restricted Stock Units | −3,334 | 6,666 | ||
| 2018-02-06 | Blake John T Senior Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2017-02-07 | Blake John T Senior Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2017-02-07 | Blake John T Senior Vice President, Finance | Grant or award · Restricted Stock Unit | +10,000 | 10,000 | ||
| 2016-09-13 | Blake John T Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2016-01-27 | Blake John T Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2016-01-04 | Blake John T Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +5,038 | 5,038 | ||
| 2015-10-28 | Blake John T Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +7,500 | 7,500 |
Page 1 of 1 · 10 trades